Eluvo Health

PUBLIC

Name	Eluvo Health
Tagline	A hybrid digital and physical healthcare provider for women in the Philippines across all life stages.
Headquarters	Parañaque, Philippines
Founded	2023
Stage	Seed
Business Model	B2C
Industry	Healthtech
Technology	Software (Non-AI)
Geography	Southeast Asia
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding Label	Undisclosed

Links

PUBLIC

• Website: https://eluvohealth.com
• LinkedIn: https://www.linkedin.com/company/eluvo-health/
• Facebook: https://www.facebook.com/61551052310841/mentions/

PUBLIC Eluvo Health is building a hybrid, women-led healthcare platform in the Philippines, targeting a systemic gap in a market where traditional care is fragmented and often stigmatized. Founded in 2023 by OB-GYN Dr. Jaycy Violago-Olivarez, the company operates from a flagship clinic in Parañaque, Metro Manila, offering consultations, diagnostics, and treatment across a woman's life stages, from fertility to menopause, supplemented by telehealth services [The Independent Investor]. Its core proposition is an integrated, patient-centric model that combines a physical location with digital support, aiming to create a safe, judgment-free environment for health conversations [Tatler Asia]. The founder's clinical background is central to the venture's credibility, with Dr. Violago-Olivarez launching the company to directly address unmet needs and societal barriers she observed in practice [Tatler Asia]. The company secured a seed round led by Foxmont Capital Partners in August 2025 to fund expansion within Metro Manila, though the specific amount remains undisclosed [Foxmont Capital Partners - Recent News & Activity, 2026]. Over the next 12-18 months, execution will be critical as the company seeks to validate its hybrid economics, scale its physical footprint, and demonstrate that its direct-to-consumer approach can achieve sustainable unit economics in a price-sensitive market.

Data Accuracy: YELLOW -- Key operational details (hybrid model, service lines, founder background) are consistently reported across multiple sources. The seed funding round and lead investor are confirmed, but the round size and valuation are not publicly disclosed.

Taxonomy Snapshot

Axis	Classification
Stage	Seed
Business Model	B2C
Industry / Vertical	Healthtech
Technology Type	Software (Non-AI)
Geography	Southeast Asia
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding	Undisclosed

Company Overview

PUBLIC

Eluvo Health was founded in 2023 by Dr. Jaycy Violago-Olivarez, an OB-GYN who identified a systemic gap in women's healthcare delivery in the Philippines [Tatler Asia]. The company is headquartered in Parañaque, Metro Manila, where it operates its flagship clinic at Parqal, Aseana City [PERPLEXITY SONAR PRO BRIEF]. Dr. Violago-Olivarez launched the venture to address unmet clinical needs and societal barriers, aiming to create a more accessible and patient-centric model of care [Tatler Asia].

Key operational milestones followed a clear, asset-heavy trajectory. The company established its first physical clinic in Parañaque, integrating in-person consultations, diagnostics, and treatment with telehealth services [PERPLEXITY SONAR PRO BRIEF]. In August 2025, Eluvo secured a seed funding round led by Foxmont Capital Partners, with proceeds earmarked to support geographic expansion within Metro Manila [Foxmont Capital Partners - Recent News & Activity, 2026], [Eluvo raises fresh funding to provide women-led healthcare for Filipino women, 2026].

Public records list the legal entity as Eluvo Healthcare Group Inc., registered in Pasay City, Metro Manila [Dun & Bradstreet]. The company's public narrative consistently emphasizes its hybrid care model and its founding mission to break taboos and foster an inclusive community for women's health decisions [About Eluvo Health].

Data Accuracy: GREEN -- Confirmed by multiple independent sources including Tatler Asia, Dun & Bradstreet, and funding announcements.

Product and Technology

MIXED

Eluvo Health’s product is a hybrid healthcare delivery model designed to consolidate fragmented services for women. The company operates a physical clinic in Parañaque, Metro Manila, which serves as the anchor for a suite of in-person consultations, diagnostics, and treatments [The Independent Investor, 2024]. This is supplemented by telehealth services and omnichannel support, creating a single point of access for care across life stages from fertility to menopause [PERPLEXITY SONAR PRO BRIEF]. The clinical approach is framed as “Talk, Test, Treat,” emphasizing patient conversation, diagnostic testing, and subsequent treatment planning within a single, judgment-free environment [About Eluvo Health].

The service scope is broad, addressing common but often stigmatized concerns. Key offerings include:

• Comprehensive consultations. Services span fertility, pregnancy and postpartum care, family planning, sexual health, hormone health, and perimenopause/menopause support [PERPLEXITY SONAR PRO BRIEF].
• Integrated diagnostics. The clinic provides on-site diagnostic services such as Pap Smears and blood tests, described as designed for patient comfort [Specialized Women's Health Checks at Eluvo Health - Animetric's World, 2026].
• Multidisciplinary care. The care team brings together OB-GYNs, mental health specialists, internists, dermatologists, and pediatricians [Venture Insights: Eluvo, 2026].

The technology enabling this model appears centered on software for appointment scheduling, patient records, and telehealth coordination, though the specific stack is not detailed in public materials. The omnichannel support suggests a digital layer for patient communication and follow-up, but the company’s public messaging focuses on the integrated care experience rather than proprietary software as a differentiator.

Data Accuracy: YELLOW -- Product details are consistently described across multiple sources, but technical implementation and software stack specifics are not publicly disclosed.

Market Research

PUBLIC

The women's health sector in the Philippines is gaining investor attention not as a niche, but as a core consumer healthcare market where unmet demand, shifting demographics, and a generational willingness to pay for convenience are converging.

Quantifying the total addressable market for a hybrid clinic model like Eluvo's requires piecing together regional and analogous data. The broader Southeast Asian digital health market was valued at approximately $6.7 billion in 2021 and is projected to reach $17.8 billion by 2027, according to a report by Ken Research [Ken Research]. While this encompasses all digital health services, it signals significant underlying growth in healthcare spending and digital adoption. More specifically, the fertility services market in the Philippines, which overlaps with a key service line for Eluvo, was estimated at $132 million in 2021 and is forecast to grow at a compound annual rate of 8.5% through 2027 [Fertility Services Market in the Philippines 2022-2027]. These figures, while not a direct TAM for Eluvo's full-spectrum offering, provide a proxy for the economic scale of one of its core verticals.

Philippines Fertility Services Market (2021) | 132 | $M
Southeast Asia Digital Health Market (2021) | 6700 | $M

The analyst takeaway is that while a precise TAM for integrated women's health clinics is not publicly modeled, the component markets are substantial and growing, suggesting a serviceable market that can support venture-scale outcomes if captured efficiently.

Demand is driven by several structural factors. A rising median age and later average age of marriage are increasing the prevalence of age-related fertility concerns and perimenopausal symptoms, creating a longer lifecycle of paid healthcare needs [The Women’s Health Concerns More Filipinas Are No Longer Keeping Quiet About, 2026]. Concurrently, increased health literacy, particularly among urban, professional women, is reducing stigma and driving proactive care-seeking for conditions like PCOS, endometriosis, and hormonal imbalances, which were historically under-diagnosed. The pandemic's acceleration of telehealth adoption has also normalized remote consultations, making hybrid care models more commercially viable from day one.

Key adjacent markets include general hospital-based OB-GYN services, which represent the incumbent but fragmented substitute, and pure-play telehealth platforms. The regulatory environment presents both a barrier and a potential moat. The Philippines' Department of Health and the Food and Drug Administration regulate medical devices, diagnostics, and telemedicine practices. Navigating clinic licensing and ensuring telehealth compliance adds operational complexity but also protects against low-quality entrants. A significant macro force is the country's National Health Insurance Program (PhilHealth), which could become a future demand-side partner if Eluvo secures accreditation for specific procedures, though this is not yet cited in public materials.

Data Accuracy: YELLOW -- Market sizing figures are from third-party industry reports, but direct TAM/SAM analysis for the specific hybrid women's health clinic model in the Philippines is not available. Demand drivers are corroborated by local media reporting.

Competitive Landscape

MIXED Eluvo Health enters a Philippine women's healthcare market characterized by a fragmented supply of services, with its hybrid model positioned against both traditional incumbents and a small set of digital-first challengers.

The competitive map can be segmented into three primary categories. First, the traditional incumbents: large hospital networks and independent OB-GYN clinics. These providers offer the physical infrastructure and medical expertise but typically lack integrated digital touchpoints and a holistic, life-stage-focused care model [The Independent Investor, 2024]. Second, a growing number of telehealth and digital health platforms, such as Kindred Health, which offer convenience and accessibility but are limited to virtual consultations and lack owned physical clinics for diagnostics and procedures [The Independent Investor, 2024]. Third, adjacent substitutes like general practice clinics and pharmacy-based consultations, which address acute needs but do not specialize in the continuum of women's health services Eluvo targets.

Eluvo's defensible edge today rests on its integrated hybrid model, combining a flagship physical clinic with telehealth and omnichannel support. This allows the company to own the entire patient journey from consultation to diagnostics and treatment in a branded environment [The Independent Investor, 2024]. The founder's background as an OB-GYN provides clinical credibility and a patient-centric design ethos, a perishable advantage if not institutionalized as the team scales [Tatler Asia, 2024]. The recent backing from Foxmont Capital Partners provides capital for geographic expansion, though the undisclosed amount makes the scale of this advantage difficult to gauge [Foxmont Capital Partners - Recent News & Activity, 2026]. The edge is durable if Eluvo can successfully replicate its clinic model and build a strong brand synonymous with modern women's healthcare before competitors can assemble similar integrated offerings.

The company is most exposed in two areas. It lacks the broad physical footprint of established hospital chains, which can use existing real estate and patient volumes. Furthermore, its B2C focus on individual women, while central to its mission, may limit the speed of customer acquisition compared to B2B2C models that partner with employers or insurers for bulk patient access. A named competitor like Kindred Health, while lacking a clinic, could potentially forge such enterprise partnerships faster due to its purely digital asset-light model.

The most plausible 18-month scenario involves a race for clinic footprint and brand dominance within Metro Manila. The winner will likely be the player that successfully opens two to three additional high-traffic locations while demonstrating strong patient retention and cross-service utilization. Eluvo, with its seed funding earmarked for new clinics, is positioned for this [The Independent Investor, 2024]. The loser in this scenario would be a pure-play telehealth provider that fails to address the diagnostic and procedural components of care, ceding the high-value, comprehensive patient relationship to hybrid models.

Data Accuracy: YELLOW -- Competitor identification and model contrasts are based on limited public coverage; the competitive landscape is inferred from market context and a single named competitor.

Opportunity

PUBLIC The potential outcome for Eluvo Health is the creation of the Philippines' first national, vertically integrated women's health brand, capturing a significant share of a historically underserved and fragmented market.

The headline opportunity is for Eluvo to become the default, trusted provider for comprehensive women's healthcare in the Philippines, moving beyond a single clinic to a network that defines the category. This outcome is reachable because the company's hybrid model directly addresses the core pain points of the current system: fragmented care, hospital-centric logistics, and persistent social stigma. By integrating physical clinics with telehealth and omnichannel support, Eluvo offers a patient-centric alternative that consolidates consultations, diagnostics, and treatment under one brand [The Independent Investor, 2024]. The recent seed funding from Foxmont Capital Partners is explicitly earmarked for opening new clinics in Metro Manila, providing the initial capital to test and scale this model beyond its flagship location [The Independent Investor, 2024]. The founder's background as an OB-GYN lends clinical credibility, while the focus on life-stage services from fertility to menopause creates a long-term patient relationship, increasing lifetime value.

Eluvo's path to scale could follow several distinct scenarios, each with a clear catalyst.

Scenario	What happens	Catalyst	Why it's plausible
Metro Manila Clinic Network	Eluvo replicates its Parqal flagship clinic model across 5-10 strategic locations in key Metro Manila cities, becoming the dominant outpatient women's health provider in the capital region.	Successful deployment of capital from the Foxmont-led seed round to open and operate 2-3 new clinics within 18 months.	The funding is specifically for geographic expansion [The Independent Investor, 2024], and the initial clinic serves as a proof-of-concept for the integrated care model.
Employer & Insurer Partnerships	The company shifts from a pure B2C model to include B2B2C, offering its hybrid care services as a bundled benefit through corporate health plans and insurance providers.	Securing a pilot partnership with a large multinational corporation or a local health maintenance organization (HMO).	The comprehensive, preventative care focus aligns with corporate wellness trends, and the telehealth component offers scalable access for distributed workforces [Foxmont Capital Partners].
Digital-First National Platform	Telehealth and digital community engagement become the primary growth engine, allowing Eluvo to serve patients across the Philippine archipelago before committing to physical expansion in each province.	A significant increase in telehealth adoption driven by a targeted marketing campaign or a partnership with a national telecom or e-commerce platform.	The company already lists telehealth as a core service [Eluvo, 2026], and digital channels can overcome geographic barriers to reach a national audience quickly.

Compounding for Eluvo would manifest as a brand and data flywheel. Each new clinic location strengthens brand recognition and trust, reducing customer acquisition costs for both physical and digital services. As the patient base grows, the company accumulates proprietary longitudinal health data specific to Filipino women across different life stages and socio-economic backgrounds. This dataset could inform more personalized care protocols, improve health outcomes, and eventually support the development of tailored wellness products or predictive health tools. Early signs of this flywheel include the company's emphasis on creating a "safe, respectful, and judgment-free space" to foster open conversations, which is a key mechanism for building patient loyalty and community [The Women’s Health Concerns More Filipinas Are No Longer Keeping Quiet About, 2026].

The size of the win, should the Metro Manila network scenario play out, can be contextualized by looking at regional comparables. While direct public peers in the Philippines are scarce, the valuation of similar hybrid care models in other emerging markets provides a reference. For instance, Indonesian women's health platform Tentang Anak reached a valuation reportedly in the tens of millions of dollars following its Series A round, demonstrating investor appetite for modernized maternal and family health services in Southeast Asia [DealStreetAsia]. If Eluvo successfully executes on its clinic expansion and captures a leading position in the Metro Manila market, a valuation trajectory into a similar range is plausible (scenario, not a forecast). The underlying addressable market is the entire spectrum of outpatient women's health services in the Philippines, a multi-billion peso segment currently dominated by traditional, non-integrated providers.

Data Accuracy: YELLOW -- The core opportunity thesis is built on confirmed product and funding details, but market sizing and valuation comparables lack specific, directly cited figures.

Sources

PUBLIC

1. [The Independent Investor, 2024] Women's health clinic Eluvo secures funding to expand care model | https://theindependentinvestor.ph/womens-health-clinic-eluvo-secures-funding-to-expand-care-model/

2. [Tatler Asia, 2024] How Eluvo Health founder and CEO Dr Jaycy Violago-Olivarez addresses challenges on women’s health | https://www.tatlerasia.com/power-purpose/front-female/dr-jaycy-violago-olivarez-eluvo-health

3. [Foxmont Capital Partners - Recent News & Activity, 2026] Foxmont Capital Partners - Recent News & Activity | https://www.crunchbase.com/organization/foxmont-capital-partners/investor_summary/overview_timeline

4. [Eluvo raises fresh funding to provide women-led healthcare for Filipino women, 2026] Eluvo raises fresh funding to provide women-led healthcare for Filipino women | https://www.dealstreetasia.com/stories/eluvo-seed-funding-foxmont-464640

5. [PERPLEXITY SONAR PRO BRIEF] PERPLEXITY SONAR PRO BRIEF | https://www.perplexity.ai

6. [About Eluvo Health] About Eluvo Health | https://eluvohealth.com/about/

7. [Dun & Bradstreet] Eluvo Healthcare Group Inc Company Profile | Pasay City, Metro Manila | Competitors, Financials & Contacts - Dun & Bradstreet | https://www.dnb.com/business-directory/company-profiles.eluvo_healthcare_group_inc.ad330dd4b7792de551b9439b1e99320f.html

8. [Specialized Women's Health Checks at Eluvo Health - Animetric's World, 2026] Specialized Women's Health Checks at Eluvo Health - Animetric's World | https://www.animetric.net/eluvo-health-parqal-mall-review.html

9. [Venture Insights: Eluvo, 2026] Venture Insights: Eluvo | https://www.crazylittlethingsilove.net/2026/04/the-womens-health-concerns-more.html

10. [The Women’s Health Concerns More Filipinas Are No Longer Keeping Quiet About, 2026] The Women’s Health Concerns More Filipinas Are No Longer Keeping Quiet About | https://www.crazylittlethingsilove.net/2026/04/the-womens-health-concerns-more.html

11. [Eluvo, 2026] Eluvo | https://eluvohealth.com

12. [Ken Research] Ken Research | https://www.kenresearch.com

13. [Fertility Services Market in the Philippines 2022-2027] Fertility Services Market in the Philippines 2022-2027 | https://www.researchandmarkets.com/reports/5622997/fertility-services-market-in-the-philippines

14. [DealStreetAsia] DealStreetAsia | https://www.dealstreetasia.com